1. Introduction {#s0005}
===============

Chronic periodontitis is an inflammatory disease that occurs due to an imbalance between the host's immune defense and specific periodontal pathogens. The disease is characterized by inflammation and the long-term destruction of the periodontal supporting tissue ([@b0085]). If the inflammation is left untreated, bacterial infiltration will increase and the resultant destruction of both the supporting tissue and the alveolar bone will likely lead to a deep periodontal pocket, which is associated with an increase in tooth loss ([@b0070], [@b0120]). There are many species of bacteria associated with chronic periodontitis, for example, *Treponema denticola*, *Porphyromonas gingivalis* and *Prevotella intermedia* ([@b0100]).

The level of chronic periodontitis can be classified as either mild, moderate, or severe. Mild periodontitis involves only slight bone loss and a 1--2 mm clinical attachment loss (CAL), while moderate periodontitis involves a greater degree of bone loss and a 3--4 mm CAL. In the case of severe periodontitis, the progression of the disease results in the severe destruction of the tooth-supporting structures and a ≥ 5 mm CAL ([@b0010]).

Fibrinogen is synthesized in the liver ([@b0110]), and its typical concentration in the blood plasma is approximately 2.5 g/l ([@b0055]). Fibrinogen plays an essential role within the body, since it is part of the acute-phase protein that becomes elevated following tissue inflammation or tissue destruction, and it also serves to increase the production of cytokines. Further, it is involved in the standard pathway of the coagulation process ([@b0080], [@b0140]). More specifically, fibrinogen converts blood clots into fibrin by means of the thrombin enzyme, which is triggered by both tissue injury and platelet activation. Fibrin molecules can clump together in order to form a solid clot, which suggests that an increase in the level of fibrinogen may pose a risk in cases of cardiovascular disease ([@b0090], [@b0140], [@b0190]).

When a bacterial invasion of the periodontal pocket occurs, the epithelial lining of the pocket experiences inflammation. As a result, the immune response initiates the production of inflammatory cytokines, which in turn prompts the liver to produce acute-phase proteins, including fibrinogen and C-reactive protein ([@b0145]).

Several studies have confirmed the relationship between periodontal disease and an increased level of fibrinogen in chronic periodontitis patients when compared to healthy subjects ([@b0005], [@b0025], [@b0035], [@b0175], [@b0195]). Moreover, [@b0065] reported the association between a patient's periodontal health status and certain cardiovascular risk factors, namely C-reactive protein and plasma fibrinogen. They concluded that a significant relationship exists between the indicators of poor periodontal health and increased levels of both C-reactive protein and fibrinogen. Additionally, patients with periodontal disease have been found to exhibit increased fibrinogen and white blood cell levels ([@b0040], [@b0090]).

Previous studies have shown the effectiveness of non-surgical periodontal therapy in terms of decreasing the fibrinogen levels after treatment when compared to the baseline levels ([@b0015], [@b0060], [@b0075], [@b0150], [@b0185]). However, some researchers have reported that the fibrinogen levels are not decreased after periodontal therapy ([@b0095], [@b0050], [@b0115], [@b0125], [@b0145]).

Due to these inconsistent findings, the present study aimed to assess the levels of fibrinogen in patients with chronic periodontitis when compared to the levels seen in healthy subjects, as well as to evaluate the effect of periodontal therapy on the fibrinogen levels in chronic periodontitis patients before and after treatment. Moreover, the study aimed to correlate the fibrinogen level with various clinical parameters in systemically healthy chronic periodontitis patients.

2. Materials and methods {#s0010}
========================

2.1. Study design {#s0015}
-----------------

The present study was an interventional controlled clinical trial in which the subjects were examined in the Department of Periodontology of the Teaching Hospital of the Dental College at Umm Alqura University. In terms of the inclusion criteria, the subjects were required to be systemically healthy according to the Cornell Medical Index ([@b0020]), non-smokers, and non-pregnant women. All the periodontitis patients involved in the study had moderate to severe chronic periodontitis (CAL ≥ 3--5 mm). A total of 30 individuals (mean age of 38 ± 25 years) were enrolled in the study. They were divided into two groups. Group 1 was the healthy control group, and it comprised 15 subjects aged between 20 and 40 years old. Group 2 was the chronic periodontitis group, and it comprised 15 patients aged between 25 and 50 years old.

2.2. Periodontal examination {#s0020}
----------------------------

The periodontal condition of each patient was ascertained using a number of clinical parameters, namely the probing pocket depth (PD), clinical attachment level (CAL) ([@b0155]), plaque index (PI) ([@b0135]), and bleeding index (BI) ([@b0030]). All the parameters were measured both before and after the periodontal treatment.

2.3. Periodontal therapy {#s0025}
------------------------

The non-surgical periodontal therapy was performed for each patient after their clinical parameters had been measured. The therapy process included the removal of the supragingival and subgingival calculus using an ultrasonic device and Gracey curettes over the course of two visits to the dental hospital. Additionally, the patients were motivated and advised regarding suitable oral hygiene techniques, such as using a toothbrush three times per day and other cleaning measures.

2.4. Blood samples {#s0030}
------------------

Five milliliters (ml) of peripheral blood were collected from both the healthy subjects and the chronic periodontitis patients before and after the treatment. The blood samples were transferred into tubes containing an anticoagulant (sodium citrate). To achieve the separation of the plasma sample, the tubes were centrifuged at 3000 rpm for 12 min. Half an hour after the collection, the plasma samples were separated in Eppendorf tubes and then stored at −80 °C until they were analyzed.

2.5. Assaying the fibrinogen levels {#s0035}
-----------------------------------

The Clauss fibrinogen assay was performed according to the standard operating procedures ([@b0045]). A clotting reaction was initiated by means of the addition of a thrombin reagent, and the time required for clot formation was measured. The coagulation signal was detected using a photo-optical method. The time required for clot formation (in seconds) was converted into the fibrinogen concentration (mg/dL) according to a local standard calibration curve prepared by testing the calibrators of each Clauss assay according to the manufacturer's instructions.

2.6. Follow up {#s0040}
--------------

The patients came after four weeks for follow up of periodontal therapy, the previous steps were performed to them again.

2.7. Statistical analysis {#s0045}
-------------------------

All the collected data were analyzed using the SPSS version 21 software program. The descriptive analysis included the minimum, maximum, mean, range, and standard deviation of the data. Student's *t*-test was used to compare between the groups, as was Spearmen\'s correlation test. The data were tabulated and graphed using Microsoft's program.

3. Results {#s0050}
==========

With regard to the periodontitis patients, the clinical parameters were improved after one month of periodontal therapy. The statistical differences for the mean BI and PD values were highly significant (P \< 0.01), while the statistical differences for the mean PI and CAL values were significant (P \< 0.05). The results are illustrated in [Table 1](#t0005){ref-type="table"}, as well as in [Fig. 1](#f0005){ref-type="fig"}, [Fig. 2](#f0010){ref-type="fig"}.Table 1Comparison of the clinical parameters (bleeding index \[BI\], plaque index \[PI\], pocket depth \[PD\], and clinical attachment level \[CAL\]) in the periodontitis group.MeanSDT-testP valueBIBefore46.3414.203.5700.003[\*\*](#tblfn2){ref-type="table-fn"}After36.0415.22  PIBefore45.6416.202.4840.026[\*](#tblfn1){ref-type="table-fn"}After38.2713.18  PDBefore2.610.6213.2050.006[\*\*](#tblfn2){ref-type="table-fn"}After2.330.480  CALBefore2.390.5172.7030.017[\*](#tblfn1){ref-type="table-fn"}After2.210.530[^1][^2]Fig. 1Demonstration of the mean plaque and bleeding index values among the chronic periodontitis patients.Fig. 2Demonstration of the mean pocket depth and clinical attachment level values among the chronic periodontitis patients.

The mean fibrinogen levels were found to be 342.26 ± 69.00 mg/dL and 352.93 ± 64.30 mg/dL for the periodontitis patient's before and after treatment, respectively. The mean level was found to be 269.85 ± 43.68 mg/dL for the healthy subjects. The statistical analysis showed a non-significant difference between the before and after fibrinogen levels of the patient group (P \> 0.05), as well as highly significant differences in the fibrinogen levels when comparing the healthy subjects and the periodontitis patients before and after treatment (P \< 0.01). The results can be seen in [Table 2](#t0010){ref-type="table"}, [Table 3](#t0015){ref-type="table"}, as well as in [Fig. 3](#f0015){ref-type="fig"}.Table 2Plasma levels of the fibrinogen baseline, follow-up, and control group.PatientFibrinogen (mg/dL)Pre interventionPost interventionHealthy group1326.00224.00323.802408.00392.00330.003224.00344.00240.004304.00236.00270.005366.00388.00266.406408.00424.00311.007394.00370.00247.008368.00332.00259.109214.00418.00283.0010306.00434.00175.2011340.00298.00294.0012396.00364.00319.0013460.00385.00281.7014340.00386.00209.0015280.00299.00238.60Table 3Statistical analysis of the fibrinogen levels (mg/dL) in the different examined groups.Fibrinogen levelsMean ± SDT-testP valueBefore treatment342.26 ± 69.000.4900.632After treatment352.93 ± 64.30Before treatment342.26 ± 69.004.2070.001[\*\*](#tblfn3){ref-type="table-fn"}Healthy269.85 ± 43.68After treatment352.93 ± 64.303.7490.002[\*\*](#tblfn3){ref-type="table-fn"}Healthy269.85 ± 43.68[^3]Fig. 3The mean fibrinogen values in the healthy and periodontitis groups.

The statistical analysis of the Pearson's correlation between the fibrinogen levels and the various clinical periodontal parameters before and after treatment indicated non-significant correlation (P \> 0.05), as can be seen in [Table 4](#t0020){ref-type="table"}.Table 4Correlation between the fibrinogen levels and the periodontal parameters.Fibrinogen levelBIPIPDCALBefore treatmentPearson′s correlation sig. (two-tailed)0.0290.0060.2850.4530.9200.9830.3030.090After treatmentPearson′s correlation sig. (two-tailed)0.1630.2590.2850.3240.5630.3520.3020.239

4. Discussion {#s0055}
=============

Periodontal disease is associated with a moderate systemic inflammatory response, while increased levels of fibrinogen are considered to indicate a high risk of cardiovascular disease ([@b0105]). The present study hence aimed to evaluate the fibrinogen levels in moderate to severe chronic periodontitis patients both before and after periodontal therapy, as well as to compare the levels with those of periodontally healthy subjects.

The assessed clinical parameters (PI, PD, CAL, and BI) were found to be improved after the non-surgical periodontal therapy. These findings were in agreement with those of previous studies ([@b0015], [@b0145]). For instance, a prospective interventional trial conducted among 35 systemically healthy subjects indicated an improvement in the assessed periodontal parameters after four months of follow-up. This finding was similar to the finding of [@b0180], who also showed an improvement in the clinical parameters after three months of follow-up, which was again similar to previously reported findings ([@b0160], [@b0175], [@b0185]).

This study aimed to clarify the potential effect of periodontal treatment in terms of modulating the fibrinogen levels in periodontitis patients, as well as to interpret the impact of periodontitis on patients' systemic inflammatory status. Some prior studies have investigated the efficacy of periodontal therapy in relation to fibrinogen as a systemic inflammatory marker ([@b0015], [@b0160], [@b0175], [@b0185]).

The findings of this study indicated that the chronic periodontitis group exhibited a higher mean fibrinogen level (342.26 ± 69.00 mg/dL) than the healthy group (269.85 ± 43.68 mg/dL). The observed difference was found to be statistically significant (P ≤ 0.01), in addition to being in agreement with certain prior studies that reported an association between the fibrinogen level and the severity of the periodontitis disease. For instance, [@b0005] reported that an increased level of the inflammatory marker correlated with the severity of the periodontitis, while [@b0165] found that the H1H2 and H2H2 genotypes played a role in the increased level of fibrinogen seen in chronic periodontitis patients ([@b0025], [@b0035], [@b0175], [@b0195]). The above-mentioned results and the supporting literature thus indicate that periodontitis may play a role in increasing the fibrinogen levels of patients.

The statistical analysis of the difference in the fibrinogen levels before treatment (342.26 ± 69.00 mg/dL) and after treatment (352.93 ± 64.30 mg/dL) indicated that the difference was non-significant, which was similar to the finding of a previously reported study ([@b0125]). That study involved 18 patients with chronic periodontitis, and the authors reported that the mean fibrinogen level did not decrease after four months of non-surgical periodontal therapy ([@b0125]). This was again similar to the finding of [@b0095], who studied the effect of periodontal therapy on the inflammatory marker. They found a non-significant decrease in the fibrinogen level as measured after six weeks of periodontal therapy. This finding is also consistent with the results of other reported studies ([@b0050], [@b0115], [@b0145]).

However, the fibrinogen levels after the periodontal therapy in this study were found to be significantly decreased when compared to the pre-treatment levels. [@b0160] performed a study on 40 healthy adult patients who had chronic periodontitis, and they showed a decrease in the improvement in the fibrinogen level after four months of periodontal treatment, which was similar to the findings of a number of other reports ([@b0015], [@b0060], [@b0075], [@b0150], [@b0180], [@b0185]). [@b0160] commented that the periodontal therapy could play a role in decreasing systemic inflammatory markers, such as fibrinogen, and improving the patient's systemic health condition. Their conclusions differ from our findings, which could be due to the short evaluation time after treatment or the low sample size in the present study.

The statistical analysis conducted in the present study revealed non-significant correlation between the fibrinogen level and the assessed clinical periodontal parameters, although this observation contrasts with the results obtained by [@b0035]. Their results indicated a weak relationship between the fibrinogen level and the indices of periodontitis.

5. Conclusion {#s0060}
=============

This study showed that both the oral health condition and periodontal therapy are essential to patients' systemic health. Further, both factors decrease the potential impact of oral microorganisms, which can be a risk factor for the progression of certain systemic disorders. With regard to fibrinogen, further studies involving larger population samples are needed to evaluate the efficacy of periodontal treatment in terms of decreasing fibrinogen levels over an extended period.
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[^1]: Significant (P \< 0.05).

[^2]: Highly significant (P ≤ 0.01).

[^3]: Highly significant (P \< 0.01).
